Ondansetron

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 85766-038
  • Package NDC 85766-038-03
  • Package NDC 85766-038-04
  • Package NDC 85766-038-06
  • Package NDC 85766-038-10
  • Package NDC 85766-038-20
  • Package NDC 85766-038-24
  • Package NDC 85766-038-30
  • Application number ANDA090469
  • SPL ID 5e7103b3-ac9e-a4c9-e063-6294a90aceda
  • SPL set ID 3c4cda2f-13d9-42c5-b449-77deb06c8de5
  • UNII 4AF302ESOS
  • RxCUI 312087

What the source publishes

Labeler
Sportpharm LLC
Active ingredients
Ondansetron
Form
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:85766-038_5e7103b3-ac9e-a4c9-e063-6294a90aceda
{
  "name": "Ondansetron",
  "splId": "5e7103b3-ac9e-a4c9-e063-6294a90aceda",
  "labels": [
    {
      "setId": "3c4cda2f-13d9-42c5-b449-77deb06c8de5",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c4cda2f-13d9-42c5-b449-77deb06c8de5",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c4cda2f-13d9-42c5-b449-77deb06c8de5"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Sportpharm LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85766-038-03)",
      "package_ndc": "85766-038-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20261022"
    },
    {
      "sample": false,
      "description": "1 BLISTER PACK in 1 CARTON (85766-038-04)  / 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
      "package_ndc": "85766-038-04",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250807"
    },
    {
      "sample": false,
      "description": "1 BLISTER PACK in 1 CARTON (85766-038-06)  / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
      "package_ndc": "85766-038-06",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250807"
    },
    {
      "sample": false,
      "description": "1 BLISTER PACK in 1 CARTON (85766-038-10)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
      "package_ndc": "85766-038-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250807"
    },
    {
      "sample": false,
      "description": "2 BLISTER PACK in 1 CARTON (85766-038-20)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
      "package_ndc": "85766-038-20",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250807"
    },
    {
      "sample": false,
      "description": "24 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85766-038-24)",
      "package_ndc": "85766-038-24",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251003"
    },
    {
      "sample": false,
      "description": "3 BLISTER PACK in 1 CARTON (85766-038-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
      "package_ndc": "85766-038-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250807"
    }
  ],
  "productId": "85766-038_5e7103b3-ac9e-a4c9-e063-6294a90aceda",
  "useDomain": "unknown",
  "dosageForm": "TABLET, ORALLY DISINTEGRATING",
  "productNdc": "85766-038",
  "deaSchedule": null,
  "genericName": "Ondansetron",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ONDANSETRON",
      "strength": "8 mg/1"
    }
  ],
  "applicationNumber": "ANDA090469",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20100412",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175817",
      "N0000175818"
    ],
    "unii": [
      "4AF302ESOS"
    ],
    "rxcui": [
      "312087"
    ],
    "spl_set_id": [
      "3c4cda2f-13d9-42c5-b449-77deb06c8de5"
    ],
    "pharm_class_epc": [
      "Serotonin-3 Receptor Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Serotonin 3 Receptor Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Sportpharm LLC"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:85766-038_5e7103b3-ac9e-a4c9-e063-6294a90aceda"